SCHEMBL5366403

SCHEMBL5366403

Cc1ccc(COC(=O)N2CCC(CNC(=O)c3cncn3C)CC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 17/20 0.58
TPSAB1 Q15661 2/20 0.54
TPSD1 Q9BZJ3 2/20 0.54
TPSG1 Q9NRR2 2/20 0.54
F2 P00734 1/20 0.54
PLG P00747 1/20 0.54
PRSS1 P07477 1/20 0.54
PRSS2 P07478 1/20 0.54
PRSS3 P35030 1/20 0.54
CYP2D6 P10635 4/20 0.49
CYP2C9 P11712 4/20 0.49
CYP3A4 P08684 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5358636 0.91 GRIN2B (0.57) GRIN2BTPSAB1TPSD1TPSG1F2
SCHEMBL5378142 0.91 GRIN2B (0.60) GRIN2BTPSAB1TPSD1TPSG1F2
SCHEMBL5358688 0.84 GRIN2B (0.60) GRIN2BTPSAB1TPSD1TPSG1F2
SCHEMBL5374920 0.82 TPSAB1 (0.66) GRIN2BTPSAB1TPSD1TPSG1F2
SCHEMBL5364341 0.82 GRIN2B (0.59) GRIN2BTPSAB1TPSD1TPSG1F2
SCHEMBL5359928 0.81 GRIN2B (0.61) GRIN2BTPSAB1TPSD1TPSG1F2
SCHEMBL5371203 0.80 NPC1L1 (0.62) GRIN2BTPSAB1TPSD1TPSG1F2
SCHEMBL5368197 0.80 TPSAB1 (0.72) GRIN2BTPSAB1TPSD1TPSG1F2
SCHEMBL5363958 0.79 TPSAB1 (0.70) GRIN2BTPSAB1TPSD1TPSG1F2
SCHEMBL5361028 0.79 TPSAB1 (0.70) GRIN2BTPSAB1TPSD1TPSG1F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7259157-B2 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists MERCK & CO., INC. (US) 2007-08-21 US disclosed
US-7259157-B2 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists MERCK & CO., INC. (US) 2007-08-21 US disclosed
US-7259157-B2 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists MERCK & CO., INC. (US) 2007-08-21 US disclosed